X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (4) 4
female (4) 4
humans (4) 4
index medicus (4) 4
middle aged (4) 4
aged (3) 3
male (3) 3
article (2) 2
cancer (2) 2
clinical trials (2) 2
disease-free survival (2) 2
hematology, oncology and palliative medicine (2) 2
oncology (2) 2
statistics (2) 2
time factors (2) 2
treatment outcome (2) 2
united states (2) 2
17 alpha-methyltestosterone treatment (1) 1
17α-methyltestosterone treatment (1) 1
abridged index medicus (1) 1
adjuvant chemotherapy (1) 1
adjuvant treatment (1) 1
adolescent (1) 1
agriculture (1) 1
algorithms (1) 1
analysis (1) 1
androgen receptor expression (1) 1
anestesi och intensivvård (1) 1
anesthesiology and intensive care (1) 1
anthracyclines (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, protozoan - immunology (1) 1
antibody response (1) 1
antigens, protozoan - administration & dosage (1) 1
antigens, protozoan - adverse effects (1) 1
antigens, protozoan - immunology (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
articles (1) 1
austria (1) 1
big data (1) 1
biomarkers, tumor - analysis (1) 1
blood (1) 1
breast cancer (1) 1
breast neoplasms - chemistry (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - pathology (1) 1
breast neoplasms - surgery (1) 1
c-terminal fragment (1) 1
cancer-surgery (1) 1
carcinoma (1) 1
care and treatment (1) 1
cdna cloning (1) 1
cell differentiation (1) 1
cell-types (1) 1
centrality (1) 1
chemotherapy, adjuvant (1) 1
cistern culture (1) 1
cohort studies (1) 1
commerce (1) 1
computer science, information systems (1) 1
criteria (1) 1
critical care - statistics & numerical data (1) 1
critical-care (1) 1
cyclophosphamide (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - adverse effects (1) 1
demographic aspects (1) 1
diffusion (1) 1
disease (1) 1
disease progression (1) 1
dose-response relationship, drug (1) 1
dose-response relationship, immunologic (1) 1
drug administration schedule (1) 1
dynamics (1) 1
endothelial growth-factor (1) 1
epirubicin - administration & dosage (1) 1
epirubicin - adverse effects (1) 1
europe - epidemiology (1) 1
feed-utilization (1) 1
fertilized ponds (1) 1
fisheries (1) 1
fishes (1) 1
fluorouracil (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - adverse effects (1) 1
freshwater & marine ecology (1) 1
gene-expression (1) 1
greedy deprecation strategy (1) 1
growth (1) 1
growth increase (1) 1
health aspects (1) 1
healthy-adults (1) 1
hepatitis (1) 1
hepatitis b (1) 1
hepatitis b vaccine (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1317 - 1325
Summary Background Neoadjuvant chemotherapy with trastuzumab for patients with HER2 -positive breast cancer can produce a pathological complete response in the... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | LAPATINIB | WOMEN | MULTICENTER | PREOPERATIVE CHEMOTHERAPY | THERAPY | ONCOLOGY | DISEASE | OPEN-LABEL | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Puerto Rico | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymph Nodes - pathology | Lymph Nodes - surgery | United States | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cyclophosphamide - adverse effects | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Grading | Fluorouracil - adverse effects | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Paclitaxel - adverse effects | Stroke Volume - drug effects | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Aged | Receptor, ErbB-2 - analysis | Neoplasm Staging | Trastuzumab | Epirubicin - adverse effects | Medical colleges | Care and treatment | Anthracyclines | Cyclophosphamide | Adjuvant treatment | Clinical trials | Breast cancer | Product development | Fluorouracil | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 962 - 972
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9847, pp. 1059 - 1065
Journal Article
Information Sciences, ISSN 0020-0255, 09/2015, Volume 316, pp. 107 - 122
The problem of target set selection for large scale social networks is addressed in the paper. We describe a novel deprecation based greedy strategy to be... 
Top-k nodes selection | Influence maximization | Social network | Big data | Target set selection | Greedy deprecation strategy | COMPUTER SCIENCE, INFORMATION SYSTEMS | MODEL | CENTRALITY | INFLUENCERS | DYNAMICS | SYSTEMS | DIFFUSION | SPREAD | Social networks | Analysis | Algorithms | Seeds | Mathematical analysis | Strategy | Criteria | Influence functions | Heuristic
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0117820
Background A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant... 
C-TERMINAL FRAGMENT | HEALTHY-ADULTS | MEROZOITE SURFACE PROTEIN-1 | SAFETY | MULTIDISCIPLINARY SCIENCES | INHIBITORY ANTIBODIES | NEW-GUINEAN CHILDREN | MONTANIDE ISA 720 | PAPUA-NEW-GUINEA | IMMUNOGENICITY TRIAL | RECEPTOR-BINDING DOMAIN | Protozoan Proteins - adverse effects | Malaria, Falciparum - prevention & control | Antigens, Protozoan - immunology | Dose-Response Relationship, Immunologic | Humans | Middle Aged | Male | Plasmodium falciparum - immunology | Dose-Response Relationship, Drug | Immunoglobulin G - immunology | Malaria Vaccines - adverse effects | Antigens, Protozoan - administration & dosage | Malaria Vaccines - immunology | Adult | Female | Antigens, Protozoan - adverse effects | Oleic Acids - adverse effects | Protozoan Proteins - administration & dosage | Mannitol - adverse effects | Antibodies, Protozoan - immunology | Hepatitis B Vaccines - administration & dosage | Merozoite Surface Protein 1 - adverse effects | India | Mannitol - analogs & derivatives | Merozoite Surface Protein 1 - administration & dosage | Malaria Vaccines - administration & dosage | Hepatitis B Vaccines - adverse effects | Merozoite Surface Protein 1 - immunology | Mannitol - administration & dosage | Adolescent | Malaria, Falciparum - immunology | Oleic Acids - administration & dosage | Hepatitis B Vaccines - immunology | Protozoan Proteins - immunology | Plasmodium falciparum | Malaria | Malaria vaccine | Immunoglobulin G | Vaccination | Clinical trials | Hepatitis B vaccine | Recombinant proteins | Vector-borne diseases | Immune response | Schizonts | Antibodies | Muscles | Vaccines | Blood | Antibody response | Proteins | Hepatitis | Randomization | Immunogenicity | Hepatitis B virus | Immunofluorescence | Hepatitis B | Recombinant | Immune system
Journal Article
Acta Universitatis Carolinae Philologica, ISSN 0567-8269, 2018, Issue 3, pp. 57 - 67
The article deals with French views on tragic emotions and their involvement as a means of katharsis as described by Aristotle in the chapter 6 of his Poetics.... 
Language and Literature Studies
Journal Article